W. Pohl (Grimmenstein, Austria), U. Costabel (Essen, Germany)
Airway obstruction in sarcoidosis A. Baran, S. Gungor, S. Bilgin, M. Yalcinsoy, B. Bagci, G. Can, E. Akkaya (Istanbul, Turkey)
| |
Health related quality of life in sarcoidosis A. Ilic, V. Vucinic, B. Gvozdenovic, V. Zugic, B. Milenkovic (Belgrade, Serbia And Montenegro)
| |
The significance of serum angiotenzin converting enzyme in diagnosing sarcoidosis S. Kasikovic Lecic, V. Kuruc, M. Ilic, G. Popovic, D. Stanojev (Sremska Kamenica, Serbia And Montenegro)
| |
Immune reponses against mycobacterial antigens in sarcoidosis M. Morishita, S. Sato, H. Maeda, H. Katoh, Y. Oki, M. Tokudome, R. I. Kamazawa, K. Kashima, M. Kusunoki, H. Miyara (Nagoya/Aichi, Seto/Aichi, Kohda/Aichi, Japan)
| |
Pulmonary function and radiological stage in newly diagnosed sarcoidosis D. Ionita, N. Bisca, R. Nemes, S. Vasile Bugarin, D. Rosca, D. Marta, C. Cilt, C. Tudose, I. Balcu, I. P. Stoicescu (Bucharest, Romania)
| |
Unusual involvements of sarcoidosis B. Gorbatâi, K. N‘guyen, E. Torabi, C. Lebreton, J. B. Auliac (Mantes la Jolie, Paris, France)
| |
Cardiac sarcoidosis presenting as a Heerfordt syndrome K. Karadakhy, M. Tangen (Fredrikstad, Oslo, Norway)
| |
The importance of inflammatory markers in sarcoidosis S. Gungor, F. Ozseker, A. Baran, M. Yalcinsoy, S. Genc, H. Eroglu, G. Can, E. Akkaya (Istanbul, Turkey)
| |
Activities of daily living and health status impairment in sarcoidosis patients B. Gvozdenovic, V. Mihailovic-Vucinic, V. Zugic, A. Dudvarski-Ilic (Belgrade, Serbia And Montenegro)
| |
Follow-up of the patients with newly diagnosed sarcoidosis treated with oral corticosteroids. Features associated with chronic sarcoidosis D. Ionita, C. Cilt, C. Tudose, N. Bisca, A. Serbescu, D. Marta, D. Bumbacea, L. Cervis, R. Nemes, C. Teleaga, I. Balcu, I. P. Stoicescu (Bucharest, Romania)
| |
Clinical, radiographic and therapeutic features of sarcoidosis in menopausal women V. Miloskovic, D. Pesut, V. Vucinic, L. Corkovic, S. Ignjatovic, B. Petrovic (Kragujevac, Belgrade, Serbia And Montenegro)
| |
The pulmonary disorders associated with autoimmune pancreatitis T. Yokoyama, H. Yamamoto, K. Kubo (Matsumoto/Nagano, Japan)
| |
Interstitial lung disease in patients with rheumatoid arthritis M. Sheyanov, V. Sulimov, S. Ternovoy, E. Fominykh, I. Zavrazhina, N. Petuhova, V. Makolkin (Moscow, Russian Federation)
| |
Pulmonary involvement in rheumatoid arthritis V. Djuric, L. Stojanovic (Belgrade, Serbia And Montenegro)
| |
Good tolerance of aspirin in Churg-Strauss syndrome W. Szczeklik, L. Mastalerz, B. Sokolowska, E. Nizankowska-Mogilnicka, M. Sanak, A. Szczeklik (Cracow, Poland)
| |
Is simvastatin a lung toxin? Clinical evidence for partially reversible interstitial lung disease after administration of simvastatin for hypercholesterinemia in ischemic vascular disease J. Weber, H. P. Eulenbruch (Gerlingen, Germany)
| |
Drug induced eosinophilic pneumonia R. Parameswari, S. Parakkal, V. Kummannoor Parameswara Pillai (Kerala, India)
| |
Correction of endothelial dysfunction in patients with pulmonary diseases N. V. Yahorava, I. S. Karpova, H. L. Hurevich, I. M. Lapteva (Minsk, Belarus)
| |